Evidence map›Paper›PMID 35589138›Full record

ArticleAJNR. American journal of neuroradiology2022

Phosphaturic Mesenchymal Tumor.

J C Benson, J A Trejo-Lopez, A M Nassiri, K Eschbacher, M J Link, C L Driscoll, R D Tiegs, J Sfeir, D R DeLone

Open access · bronzeAbstract read
In one paragraph

Article in AJNR. American journal of neuroradiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 24 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Phosphaturic Mesenchymal Tumor: From Invisibility to Bedridden Morbidity.Journal of the ASEAN Federation of Endocrine Societies · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

J C BensonFrom the Department of Radiology (J.C.B. D.R.D.), Mayo Clinic, Rochester, Minnesota benson.john3@mayo.edu.ORCID 0000-0002-4038-5422
J A Trejo-LopezDepartment of Laboratory Medicine and Pathology (J.A.T.-L., K.E.), Mayo Clinic, Rochester, Minnesota.ORCID 0000-0001-5346-7753
A M NassiriDepartment of Otorhinolaryngology (A.M.N., C.L.D.), Mayo Clinic, Rochester, Minnesota.ORCID 0000-0001-9665-1868
K EschbacherDepartment of Laboratory Medicine and Pathology (J.A.T.-L., K.E.), Mayo Clinic, Rochester, Minnesota.ORCID 0000-0002-8522-2723
M J LinkDepartment of Neurosurgery (M.J.L.), Mayo Clinic, Rochester, Minnesota.ORCID 0000-0002-2102-6897
C L DriscollDepartment of Otorhinolaryngology (A.M.N., C.L.D.), Mayo Clinic, Rochester, Minnesota.ORCID 0000-0001-8482-3968
R D TiegsDepartment of Endocrinology (R.D.T., J.S.), Mayo Clinic, Rochester, Minnesota.ORCID 0000-0002-8289-3222
J SfeirDepartment of Endocrinology (R.D.T., J.S.), Mayo Clinic, Rochester, Minnesota.ORCID 0000-0003-1576-1534
D R DeLoneFrom the Department of Radiology (J.C.B. D.R.D.), Mayo Clinic, Rochester, Minnesota.ORCID 0000-0002-4211-8790
Mayo Clinic · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Phosphaturic mesenchymal tumors (PMTs) are neoplasms associated with tumor-induced osteomalacia. Patients typically present with pathologic fractures in the setting of chronic hypophosphatemic hyperphosphaturic osteomalacia, as well as gradual muscle weakness, bone pain, and difficulty walking. Because of their rarity and nonspecific symptomatology, phosphaturic mesenchymal tumors often go undiagnosed for years. Even when discovered on imaging, the tumors can be diagnostically challenging for radiologists. Phosphaturic mesenchymal tumors often tend to be small and can be located nearly anywhere in the body, and, therefore, can mimic many other tumors. This case highlights the imaging and pathologic markers of a phosphaturic mesenchymal tumor, often found in a patient with tumor-induced osteomalacia.

Indexed as

MesenchymomaNeoplasms, Connective TissueOsteomalaciaParaneoplastic SyndromesHumans

Identifiers

PMID35589138
PMCPMC9172954
OpenAlexW4280600523

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.